News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tesaro, Inc. (TSRO) To Present At The UBS 2014 Global Healthcare Conference


5/14/2014 11:48:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WALTHAM, Mass., May 14, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, and Dr. Mary Lynne Hedley, president of TESARO, will present at the UBS 2014 Global Healthcare Conference on Wednesday, May 21, 2014 at 8:00 a.m. Eastern time at the Sheraton New York Times Square Hotel.

A live webcast will be accessible via the Investors page of the TESARO website at www.tesarobio.com. An archived replay of this webcast will be available on the Company's website for 14 days after the conference.

About TESARO

TESARO, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

CONTACT: For further information, please contact:
Jennifer Davis
Sr. Director, Corporate Development & Investor Relations
1.781.325.1116
jdavis@tesarobio.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES